key: cord-0851713-w570qm6i authors: Schultheiß, Christoph; Paschold, Lisa; Willscher, Edith; Simnica, Donjete; Wöstemeier, Anna; Muscate, Franziska; Wass, Maxi; Eisenmann, Stephan; Dutzmann, Jochen; Keyßer, Gernot; Gagliani, Nicola; Binder, Mascha title: Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19 date: 2021-10-23 journal: iScience DOI: 10.1016/j.isci.2021.103325 sha: d4727a1d5ce5e214f534cd552701044f45663368 doc_id: 851713 cord_uid: w570qm6i In parasite and viral infections, aberrant B cell responses can suppress germinal center reactions thereby blunting long-lived memory and may provoke immunopathology including autoimmunity. Using COVID-19 as model, we set out to identify serological, cellular and transcriptomic imprints of pathological responses linked to autoreactive B cells at single-cell resolution. We show that excessive plasmablast expansions are prognostically adverse, correlate with auto-antibody production, but do not hinder the formation of neutralizing antibodies. While plasmablasts followed IL-4 and BAFF driven developmental trajectories, were polyclonal and not enriched in autoreactive B cells, we identified two memory populations (CD80+/ISG15+ and CD11c+/SOX5+/T-bet+/-) with immunogenetic and transcriptional signs of autoreactivity that may be the cellular source of auto-antibodies in COVID-19 and that may persist beyond recovery. Immunomodulatory interventions discouraging such adverse responses may be useful in selected patients to shift the balance from autoreactivity towards long-term memory. Prognostically unfavorable expansion of CD20 dim/plasmablasts in individuals 104 with acute COVID-19 105 We quantified peripheral PB by flow cytometry within 4 weeks after disease onset 106 (median sampling at day 15, range 0-26; Figure S1A -B) in active COVID-19 patients 107 (pt) as well as d14+/-7 after influenza vaccination using a broad gating strategy (CD3 -108 /CD19 +/dim /CD20 dim/-/SSC dim or high ) to cover all stages of PB development as previously that the BCR repertoires of PB high COVID-19 patients were less diverse, more clonal 127 and associated with higher levels of SHM as compared to PB low patients, recovered 128 individuals and healthy controls ( Figure S1F ). In addition, we did not detect any 129 differences in complementarity-determining region 3 (CDR3) length distribution or 130 amino acid composition between groups (Figure S1G-I). 131 132 COVID-19 patients with high CD20 dim/plasmablast counts show normal SARS-133 CoV-2 antibody titers but a specific cytokine pattern 134 S1-or nucleocapsid protein (NCP)-specific SARS-CoV-2 IgG antibody titers did not 135 appear to differ between patients with high CD20 dim/plasmablast counts and the rest 136 of the cohort, while S1-IgA titers were more abundant in the PB high group ( Figure 1G ). Moreover, patients with high CD20 dim/plasmablast levels showed a cytokine profile 138 including high levels of IFN-γ and IL-6 consistent with the severity of their disease 139 ( Figure 1H ). These patients also had high plasma levels of BAFF, IL-10 and IL-4 which 140 are known to promote the generation and survival of plasmablasts ( Figure 1H ). Consistent with prior evidence, antibody titers decreased over time in almost all 142 patients with adequate follow-up ( Figure S1J ). Since plasma autoantibodies were preferentially found in COVID-19 patients of the 234 PB high subset, we reasoned that they might directly be generated by the PB population. for isotype-switched IGHV4-34-AVY B cells in the single-cell dataset ( Figure 6B ). These switch events extended to different IGHV4-34 rearrangements ( Figure 6C ). Contrary to our initial hypothesis, we did not observe an enrichment of these 248 rearrangements in the CD20 dim/-PB populations but in CD27 + memory-like populations 249 independent of disease state (A6, corresponding to memory population R4 in A0 A1 A2 A3 A4 A5 A6 scRNA-seq -CD19 + B cells -recovered COVID-19 IFRD1 SAT1 TUT4 RB1CC1 MACF1 FTX NFKBID IRF1 TGFBR2 DENND4A SNHG14 S100A10 IFIT2 ITGB1 TEX9 COCH ANXA2 CPNE5 IFI30 HOPX JPT1 TCL1A PLPP5 FCER2 CXCR4 IL4R TNFRSF13B CD27 GPR183 HLA−B RPS3 B2M RPS28 RPS18 HLA−A RPS14 JCHAIN COTL1 EEF2 VIM GAPDH AHNAK ALKBH7 LINC01857 MALAT1 AC004687.1 STAT1 CD83 CDK12 SLC38A11 KIAA1109 TTC21B NR4A2 IL10RA SKAP1 IRF1 GABPB1−AS1 NFKBIZ FOSB SLC2A3 NEAT1 TNFAIP3 IFRD1 MEF2A CRIP1 HCK PPP1R14A CD1C PLAC8 IFI30 SH3BGRL3 PLEK CIB1 ACP5 EMP3 S100A4 LINC01781 CPNE5 S100A6 HSPA8 ITGB1 NFKBIA GSTK1 S100A10 KLF10 ACTG1 PDE4D TEX9 COCH RPS6 RPS27 TPT1 HIST1H2BK CEP85L BRD8 FP236383.5 PIM3 AC007952.4 GCSAM EEF1A1 TXNIP RPL26 DDIT3 RPL3 RPS2 PRCD RPS12 TSC22D3 TUBA4A UMAP1 UMAP2 80 BAFF selectively enhances the survival of plasmablasts generated from 730 human memory B cells Antibody repertoire analysis in 732 polygenic autoimmune diseases Longitudinal Multi-omics Analyses Identify Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19 MiXCR: software for comprehensive adaptive immunity profiling scRepertoire: An R-based toolkit for single-cell 741 immune receptor analysis Anti-Phospholipid Antibodies in COVID-19 Are Different From Those 744 Detectable in the Anti-Phospholipid Syndrome Network Analysis Identifies Proinflammatory 747 Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity Viral infection and reactivation in autoimmune disease Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 752 patients in China Expansion of plasmablasts and loss of memory B cells in peripheral 755 blood from COVID-19 patients with pneumonia Single-cell sequencing of plasma cells 758 from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing 759 antibodies to SARS-CoV-2. bioRxiv COVID-19, Antiphospholipid Antibodies, 761 and Catastrophic Antiphospholipid Syndrome: A Possible Association Germinal Center and Extrafollicular B Cell Responses in 764 Vaccination Deconstructing Olfactory Stem Cell Trajectories at Single-Cell Resolution Autoimmune and inflammatory diseases following COVID-19 Deep Sequencing of B Cell Receptor 772 Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures An Integrated Multi-omic Single-Cell Atlas of Human B Cell 776 Identity Immunization-induced perturbation of human blood plasma cell pool: progressive maturation, IL-6 779 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-780 specific and nonspecific plasma cells A B-cell subset uniquely 782 responsive to innate stimuli accumulates in aged mice Targeting B Cells and Plasma Cells in Autoimmune 784 Diseases The role of IFN-gamma in 789 regulating Nfkbiz expression in epidermal keratinocytes Reactive plasmacytoses are expansions of plasmablasts retaining the 792 capacity to differentiate into plasma cells Extrafollicular responses in 794 humans and SLE Characterization of a transitional preplasmablast population in the process 797 of human B cell to plasma cell differentiation An in vitro model of differentiation of memory B cells into plasmablasts and 800 plasma cells including detailed phenotypic and molecular characterization Loss of Bcl-6-Expressing T Follicular Helper Cells and 803 Germinal Centers in COVID-19 T-bet(+) memory B cells: Generation, function, and fate Longitudinal Isolation of Potent Near-Germline SARS-CoV-808 2-Neutralizing Antibodies from COVID-19 Patients B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory 810 factor (IRF)-1, and IRF-2 can bind to the same regulatory sites Comprehensive mapping of immune 813 perturbations associated with severe COVID-19 A simple method for displaying the hydropathic character of a 815 protein Transcriptional regulation of memory B cell differentiation The I binding specificity of 819 human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and 820 complementarity determining region 3 Repression of the B cell identity factor Pax5 is not required for plasma cell development Extrafollicular antibody responses BRepertoire: a user-friendly web server for analysing antibody repertoire data Deep immune profiling of COVID-19 patients 831 reveals distinct immunotypes with therapeutic implications Versatile functions for IL-6 in metabolism and cancer Multifunctional role of the transcription factor Blimp-1 in 836 coordinating plasma cell differentiation Immune Defense in Upper Airways: A Single-Cell Study of Pathogen-Specific Plasmablasts and Their 839 Migratory Potentials in Acute Sinusitis and Tonsillitis ISG15 in antiviral immunity and beyond The Magnitude of IFN-gamma Responses Is Fine-Tuned by 844 DNA Architecture and the Non-coding Transcript of Ifng-as1 Evidence for involvement of a 846 hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood 847 cell I antigen Identification of Pax5 target genes in early B cell differentiation High levels of SOX5 decrease proliferative capacity of human B cells, but 852 permit plasmablast differentiation The IBD-associated long noncoding RNA IFNG-AS1 regulates the balance 855 between inflammatory and anti-inflammatory cytokine production after T-cell stimulation Neutrophils in COVID-19 Plasmodium DNA-mediated TLR9 activation of T-bet(+) B cells 861 contributes to autoimmune anaemia during malaria BAFF, IL-4 and IL-21 separably program germinal center-like phenotype acquisition, BCL6 864 expression, proliferation and survival of CD40L-activated B cells in vitro Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c(+) B-cell population is important for 867 the development of autoimmunity Sexual dimorphism in autoimmunity Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell 872 Populations Plasma cell differentiation is 874 controlled by multiple cell division-coupled epigenetic programs Next-Generation Sequencing of T and B Cell Receptor 877 Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease Trafficking receptor signatures define blood plasmablasts responding to tissue-880 specific immune challenge Analysis of a SARS-CoV-2-Infected Individual Reveals 883 Development of Potent Neutralizing Antibodies with Limited Somatic Mutation Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms IFNG-AS1 Enhances Interferon Gamma Production in Human 890 Transcriptomic Analyses Define Distinct Peripheral B Cell Subsets and Discrete Development Pathways. 893 Front Immunol 12 Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics Comprehensive Integration of Single-Cell Data LncRNAs in the Type I Interferon Antiviral 901 Response Diversity, cellular origin and autoreactivity of antibody-secreting cell 904 population expansions in acute systemic lupus erythematosus Design and standardization of PCR primers and 907 protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect 908 lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Infection-induced plasmablasts are a nutrient sink that 912 impairs humoral immunity to malaria The Immune Epitope Database (IEDB): 2018 update Autoantibodies related to systemic autoimmune rheumatic diseases in 918 severely ill patients with COVID-19 B cell analysis in SARS-CoV-2 versus malaria: 921 Increased frequencies of plasmablasts and atypical memory B cells in COVID-19 Extrafollicular B cell responses correlate with neutralizing 925 antibodies and morbidity in COVID-19 Rapid and massive virus-specific 928 plasmablast responses during acute dengue virus infection in humans Mechanisms for the induction of autoimmunity by infectious agents IFITM1 plays an essential role in the antiproliferative action 932 of interferon-gamma Highlights • Plasmablast expansions correlate with disease severity and autoantibodies in p t 6 5 p t 6 7 p t 6 8 p t 6 9 p t 7 0 p t p t 3 p t 9 p t 2 5 p t 4 4 p t 1 0 0 p t 1 0 6 p t 1 1 6 p t 1 1 7 p t 1 1 8 p t 1 p t 5 p t 6 p t 7 p t 8 p t 1 0